Literature DB >> 31611024

[Adaptation of the General Data Protection Regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK-air®)].

D Laune1, S Arnavielhe1, F Viart2, A Bedbrook3, J Mercier4, G Lun San Luk4, G deVries5, O Spreux6, J Bousquet7.   

Abstract

The General Data Protection Regulation (GDPR) regulates the processing of personal data in the European Union. The legal context is adapted to follow the evolution of technologies and of society. This new European regulation became mandatory, especially for connected devices, on May 25, 2018. An app originally known as "The Allergy Diary" is available for Android phones and iPhones. Its name was recently changed to MASK-air. The downloading and use of this app are free of charge and there are no adverts. It enables users to record their symptoms and their medications to better track the progress of their allergic rhinitis and/or asthma. It has been developed by public (Foundation FMC VIA-LR, University of Montpellier) and private (KYomed INNOV) organizations based in France and therefore falls under French jurisdiction. This article summarizes the five main principles of personal data protection to be respected during the development of the app: purpose, proportionality and relevance, limited retention period, security and confidentiality, as well as the rights of the people who are involved in the management of the personal data (including withdrawal and modification).
Copyright © 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Application mobile; Asthma; Asthme; De-identification; Données de santé; Dé-identification; GDPR; General Data Protection Regulation; Geolocation; Géolocalisation; Health data; MASK; RGPD; Rhinite; Rhinitis; Règlement général sur la protection des données; Smartphone app

Mesh:

Year:  2019        PMID: 31611024     DOI: 10.1016/j.rmr.2019.08.003

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  4 in total

Review 1.  Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

Authors:  Bernardo Sousa-Pinto; Patrik Eklund; Oliver Pfaar; Ludger Klimek; Torsten Zuberbier; Wienczyslawa Czarlewski; Annabelle Bédard; Carsten Bindslev-Jensen; Anna Bedbrook; Sinthia Bosnic-Anticevich; Luisa Brussino; Victoria Cardona; Alvaro A Cruz; Govert de Vries; Philippe Devillier; Wytske J Fokkens; José Miguel Fuentes-Pérez; Bilun Gemicioğlu; Tari Haahtela; Yunen Rocío Huerta-Villalobos; Juan Carlos Ivancevich; Inger Kull; Piotr Kuna; Violeta Kvedariene; Désirée E Larenas Linnemann; Daniel Laune; Michael Makris; Erik Melén; Mário Morais-Almeida; Ralph Mösges; Joaquim Mullol; Robyn E O'Hehir; Nikolaos G Papadopoulos; Ana Margarida Pereira; Emmanuel P Prokopakis; Fotis Psarros; Frederico S Regateiro; Sietze Reitsma; Boleslaw Samolinski; Nicola Scichilone; Jane da Silva; Cristiana Stellato; Ana Todo-Bom; Peter Valentin Tomazic; Sanna Toppila Salmi; Antonio Valero; Arunas Valiulis; Erkka Valovirta; Michiel van Eerd; Maria Teresa Ventura; Arzu Yorgancioglu; Xavier Basagaña; Josep M Antó; Jean Bousquet; João Almeida Fonseca
Journal:  Clin Transl Allergy       Date:  2021-09-19       Impact factor: 5.657

Review 2.  Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing.

Authors:  J Bousquet; J Farrell; M Illario
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

3.  Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model.

Authors:  Bernardo Sousa-Pinto; Luís Filipe Azevedo; Ana Sá-Sousa; Rafael José Vieira; Rita Amaral; Ludger Klimek; Wienczyslawa Czarlewski; Josep M Anto; Anna Bedbrook; Violeta Kvedariene; Maria Teresa Ventura; Ignacio J Ansotegui; Karl-Christian Bergmann; Luisa Brussino; G Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Thomas Casale; Lorenzo Cecchi; Tomás Chivato; Derek K Chu; Cemal Cingi; Elisio M Costa; Alvaro A Cruz; Giulia De Feo; Philippe Devillier; Wytske J Fokkens; Mina Gaga; Bilun Gemicioğlu; Tari Haahtela; Juan Carlos Ivancevich; Zhanat Ispayeva; Marek Jutel; Piotr Kuna; Igor Kaidashev; Helga Kraxner; Désirée E Larenas-Linnemann; Daniel Laune; Brian Lipworth; Renaud Louis; Michaël Makris; Riccardo Monti; Mario Morais-Almeida; Ralph Mösges; Joaquim Mullol; Mikaëla Odemyr; Yoshitaka Okamoto; Nikolaos G Papadopoulos; Vincenzo Patella; Nhân Pham-Thi; Frederico S Regateiro; Sietze Reitsma; Philip W Rouadi; Boleslaw Samolinski; Milan Sova; Ana Todo-Bom; Luis Taborda-Barata; Peter Valentin Tomazic; Sanna Toppila-Salmi; Joaquin Sastre; Ioanna Tsiligianni; Arunas Valiulis; Dana Wallace; Susan Waserman; Arzu Yorgancioglu; Mihaela Zidarn; Torsten Zuberbier; João Almeida Fonseca; Jean Bousquet; Oliver Pfaar
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

4.  Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study.

Authors:  Alida Benfante; Bernardo Sousa-Pinto; Gianluca Pillitteri; Salvatore Battaglia; Joao Fonseca; Jean Bousquet; Nicola Scichilone
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.